Are There Many Chinese Patients for IVF in Thailand - Reality and Trends of Chinese Patients Seeking IVF in Thailand
Opening: Real consultation scenario
Last month, a 40-year-old patient found me through an online consultation platform. Her AMH was 0.8, FSH 11.2, and she had one IVF cycle locally with no usable embryos. She asked a very practical question: "Are there many Chinese patients for IVF in Thailand now? I'm worried it will be as crowded as a top-tier public hospital in China, with assembly-line treatment." This question seems simple, but it involves multiple layers including cross-border medical resource allocation, positioning differences among different reproductive centers, and patient decision-making paths. As a consultant with ten years of experience, I handle hundreds of similar cases every year. Today, I will break down the real situation clearly.
Actual Situation of Chinese Patients for IVF in Thailand
Direct answer: In specific private reproductive centers in Bangkok, Thailand, the proportion of Chinese patients is indeed relatively high, but the degree of "many" varies depending on the center's positioning, service type, and period, and is not a universal phenomenon across the country.
Specifically, in several private reproductive centers in Bangkok that focus on international patients, the proportion of Chinese patients (including mainland China, Hong Kong, Macau, and Taiwan) could reach 40% to 60% before the pandemic, and even higher in some centers. However, Thailand also has a large number of public hospital reproductive centers and medium-sized clinics that primarily serve local patients, where the proportion of Chinese patients is very low, usually less than 5%. Therefore, the answer to "Are there many Chinese patients for IVF in Thailand?" depends on which type of center you are asking about.
Why Chinese Patients Are Concentrated in the Thai IVF Market
This is not accidental but the result of several overlapping factors:
- Geographic and transportation convenience: It takes only 3-5 hours to fly from major Chinese cities to Bangkok, allowing flexible round trips, suitable for IVF cycles requiring multiple visits.
- Policy and legal environment: Thailand has relatively fewer restrictions on technologies like PGT (Preimplantation Genetic Testing), egg donation, and sperm donation. Some projects that cannot be carried out or are strictly limited in China can be legally performed in Thailand.
- Services and language support: Leading Thai reproductive centers generally have Chinese translators, Chinese coordinators, and even dedicated service teams for Chinese patients, lowering communication barriers.
- Relatively controllable costs: Compared to the US (approximately $25,000-$40,000/cycle), the cost of IVF in Thailand is about $8,000-$15,000/cycle, offering a more prominent cost-performance ratio among cross-border options.
However, it should be noted that these factors are also changing dynamically. In the past two years, assisted reproductive technology in China has developed rapidly, and some city medical insurance has begun to cover IVF projects, causing some patients who would have gone to Thailand to choose domestic treatment instead.
Horizontal Comparison of Chinese Patient Numbers: Thailand vs. Other Destinations
To understand the degree of "many" more objectively, we can compare several major cross-border IVF destinations:
| Destination | Relative Number of Chinese Patients | Main Characteristics |
|---|---|---|
| Thailand | Relatively high, concentrated in Bangkok private centers | Close distance, good cost-performance ratio, good language support, relaxed policies |
| United States | Moderate to low, but concentrated high-end demand | Comprehensive technology, complete legal framework, highest cost, long distance |
| Malaysia | Relatively low, but growing fast | Islamic law affects some technologies, lower cost than Thailand, convenient for Chinese communication |
| Japan | Relatively low, mainly for mild stimulation and advanced age conditioning | Meticulous technology, strict policies, high language barrier, long cycles |
| Cambodia/Laos | Increased in recent years, but small base | Very relaxed policies, low cost, uneven medical support |
In absolute numbers, Thailand is one of the most concentrated destinations for Chinese cross-border IVF patients. However, "concentration" does not mean "suitable for everyone." Different destinations suit different groups, which will be analyzed in detail later.
Three Most Easily Overlooked Details
Detail 1: The concentration of Chinese patients is strongly correlated with the center's marketing strategy
Some reproductive centers in Thailand regard the Chinese market as their main source of income, investing heavily in Chinese-language promotion, building domestic referral networks, and even setting up offices in China. The proportion of Chinese patients in such centers is naturally very high. Other centers focus on the local market, with a very low proportion of international patients. Therefore, it is not possible to say generally that "there are many Chinese patients for IVF in Thailand"; the type of center must be distinguished.
Detail 2: The recovery structure after the pandemic has changed
After Thailand fully resumed international medical travel in 2023, the number of Chinese patients is indeed recovering, but the structure has changed: previously, the main demands were "first-time IVF" and "gender selection"; now, there are more complex cases such as "seeking second-line solutions after repeated domestic failures," "advanced age with low ovarian reserve," and "need for PGT or egg donation." The number of people going purely for gender selection is decreasing. The current group of Chinese patients has more complex medical conditions and makes more rational decisions.
Detail 3: The number of local Thai patients is also growing
The infertility rate in Thailand itself is also rising. Coupled with the Thai government's strategy of making "medical tourism" a national priority, both local and international patients are increasing. Therefore, even if the absolute number of Chinese patients is recovering, their proportion in some centers may actually decline because local patients are growing faster. Proportion and number are two different concepts that need to be viewed separately.
Practitioner Observation: Trends I Have Seen in the Past Three Years
From entering the industry in 2016 to now, I have handled over 600 cases of IVF in Thailand. Several obvious changes are worth mentioning:
- The age of patients is rising: From 2017 to 2019, the average age of patients going to Thailand was about 36; now it is about 39. Those over 38 account for more than half.
- The number of previous treatments is increasing: Now, over 60% of patients have had at least one IVF cycle in China, and some have had 3-5 cycles. They go to Thailand not to "try casually" but as a "last hope."
- Understanding of success rates is more rational: Previously, many people asked, "Is the success rate in Thailand 80%?" Now, more people ask, "What level is my AMH and age in Thailand?" or "Does this center have a specific plan for advanced age?"
- Awareness of legal risks is increasing: Before 2020, many patients were unclear about the legal boundaries of IVF in Thailand. Now, most people proactively ask whether egg donation, sperm donation, surrogacy, and gender selection are legal, and how to avoid risks.
A real practitioner's judgment: The "quantity dividend" period for Chinese patients seeking IVF in Thailand has passed, and it has entered a stage of "quality competition." Simply relying on the label "Thailand IVF" is no longer enough to attract patients. What truly retains Chinese patients is medical quality, case management ability, and transparent information communication.
Frequently Asked Questions: Real Confusions About "Chinese Patients"
It depends on the center. In centers with a high concentration of Chinese patients, there may indeed be tight scheduling and pressure on medical resources, especially on egg retrieval and transfer days. However, most private centers in Thailand operate on an appointment system, with a fixed doctor and coordinator following up on each cycle, so it is not like the assembly line in domestic public hospitals. When choosing a center, it is recommended to ask directly: "Does the doctor personally perform the ultrasound and egg retrieval for each cycle?" and "Is the coordinator 1-on-1 or 1-on-many?" These two questions can filter out many overcrowded institutions.
For women: AMH, sex hormone panel (days 2-4 of menstruation), antral follicle count (AFC), chromosome karyotype, complete blood count, coagulation function, thyroid function, infectious disease screening (Hepatitis B, Hepatitis C, HIV, Syphilis), uterine ultrasound, breast ultrasound. For men: semen analysis (including morphology and DNA fragmentation rate), chromosome karyotype, infectious disease screening. Most of these tests can be done in domestic top-tier hospitals and are valid for 6-12 months. Thai reproductive centers generally accept reports from domestic top-tier hospitals, but some centers require certain items to be rechecked locally in Thailand. It is recommended to send all reports to the center for preliminary review before departure to avoid a wasted trip.
Standard process: Initial consultation + ovarian stimulation takes about 12-14 days (requires stay in Thailand). Embryos are formed 3-5 days after egg retrieval. If PGT is done, it takes 7-14 days for results. Then, frozen embryo transfer requires another trip to Thailand (about 5-7 days). Therefore, a complete cycle usually requires 2 trips to Thailand, each lasting 10-14 days, with an interval of 1-2 months between trips. If egg retrieval and transfer are completed in one trip (without PGT), it can be shortened to one trip of about 18-22 days. However, the specific time depends on your ovarian stimulation plan and embryo development.
Suitable people: Those with repeated IVF failures in China, those needing PGT (especially for chromosomal abnormalities or single-gene disorders), advanced age (over 38) with poor egg retrieval results in China, those needing egg or sperm donation (must confirm legality), and those with a clear need for gender selection (must confirm institutions allowed by Thai law). Unsuitable people: Those without clear medical indications, those under significant financial pressure and unable to bear the risk of failure, those completely unaware of cross-border medical risks, those with extremely poor ovarian function (AMH < 0.3 and basal follicles < 2) with overly high expectations, and those with weak legal awareness and unwilling to purchase overseas medical insurance. Going to Thailand for IVF is not a "last straw" but a medical decision that requires rational evaluation.
How Thai Reproductive Doctors View the Chinese Patient Group
Several Thai reproductive doctors I have worked with long-term (including doctors from centers like ART, Jetanin, BIAW, etc.) have shared in private conversations that their general feedback on Chinese patients is: "Chinese patients do thorough homework, but sometimes they suffer from information overload and are prone to anxiety."
Specifically, Thai doctors observe:
- Chinese patients often come for consultations with a large number of domestic test reports and literature, and have their own ideas about treatment plans. This is good in itself, but sometimes individual differences are overlooked.
- Some Chinese patients have an irrational obsession with "success rates," believing that IVF in Thailand will definitely succeed, ignoring the limitations of their age and ovarian reserve.
- Chinese patients generally have a lower tolerance for "pain" and "medication side effects" compared to Western patients, requiring more psychological support and communication.
The doctors' advice is: Before going to Thailand for IVF, first complete a comprehensive fertility assessment in China to clarify your core issues (whether it is low egg count, poor embryo quality, or uterine problems), and then go with a clear goal to find a matching center. Do not go with the mindset of "trying my luck in Thailand." The time and financial costs of cross-border medical care are very high.
Special Situations: Chinese Patients with Low AMH, Advanced Age, and Repeated Failures
This category of patients is currently the main force among Chinese people going to Thailand. For patients with AMH below 1.0 and age over 40, Thai doctors usually recommend:
- First, do a "diagnostic egg retrieval" (i.e., not aiming for transfer, but first seeing the number of eggs retrieved and embryo quality), then decide whether to continue.
- Consider a "cumulative cycle" strategy: do 2-3 egg retrievals consecutively to accumulate enough embryos before doing PGT and transfer.
- If it is extremely difficult to retrieve eggs on your own, discuss the backup plan of egg donation in advance.
Note: Not all centers in Thailand are skilled in handling patients with advanced age and low ovarian reserve. Some centers market themselves with "young patients + high success rates," and their protocols for advanced-age patients may not necessarily be better than those in China. When choosing a center, check whether the center has a specialized protocol for advanced age/low ovarian reserve and whether it has real case experience in handling patients over 40.
Risk reminder: Cross-border assisted reproduction involves multiple risks including medical, legal, financial, and language risks. Although there are many Chinese patients for IVF in Thailand and services are relatively mature, it is not suitable for everyone. The following risks need careful evaluation:
- Medical risk: There are differences in medical standards, medication habits, and laboratory standards between Thailand and China, which may lead to communication errors or plan incompatibility.
- Legal risk: Thailand has clear legal provisions on egg donation, sperm donation, surrogacy, and gender selection, and enforcement has become stricter in recent years. Be sure to confirm legality through official channels and do not trust verbal promises from intermediaries.
- Financial risk: Cross-border IVF costs are not transparent. Hidden fees (such as translation fees, coordination fees, expedited test fees, embryo freezing fees, etc.) can account for 20%-30% of the total cost. Before signing a contract, request a complete detailed cost list.
- Psychological risk: Facing treatment failure in a foreign country, lacking support from family and familiar surroundings, the psychological pressure can be greater than at home. It is recommended to prepare a psychological plan before departure and confirm whether the center provides psychological support services.
My suggestion is: Before deciding to go to Thailand, first complete a comprehensive fertility assessment and consultation in China to clarify your medical indications and expectations. If you indeed need to seek a cross-border solution, compare at least 2-3 Thai centers and request a written treatment plan and cost estimate. Do not be guided by the phenomenon of "many Chinese patients" itself, but find a center that truly matches your personal situation.
This article is compiled based on industry practitioner observations and public medical information, and does not constitute specific medical advice or institutional recommendations. Each patient's situation has individual differences; please refer to the face-to-face evaluation of a reproductive doctor.
IVF Thailand Chinese patients Cross-border assisted reproduction AMH Advanced age IVF PGT Overseas IVF preparation
